MARKET

QNCX

QNCX

Quince
NASDAQ
0.2000
-0.0255
-11.31%
After Hours: 0.1876 -0.0124 -6.20% 19:59 02/13 EST
OPEN
0.2806
PREV CLOSE
0.2255
HIGH
0.2975
LOW
0.1911
VOLUME
181.50M
TURNOVER
--
52 WEEK HIGH
4.550
52 WEEK LOW
0.1251
MARKET CAP
11.14M
P/E (TTM)
-0.1640
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 1d ago
Vanguard Total Stock Market ETF (VTI) Daily Update—2/13/26
TipRanks · 1d ago
3 Penny Stocks to Watch Now, 2/13/26
TipRanks · 1d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 1d ago
What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours
Benzinga · 1d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 2d ago
Quince Therapeutics Stock Plunges As Filing Shows Reverse Merger Plans, Bankruptcy Risks
Benzinga · 2d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 2d ago
More
About QNCX
Quince Therapeutics, Inc. is a late-stage biotechnology company. The Company is engaged in unlocking the patient’s own biology to deliver life-changing therapeutics to those living with rare diseases. Its proprietary autologous intracellular drug encapsulation (AIDE) technology platform is a drug/device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The Company’s Phase III lead asset, eDSP, leverages its AIDE technology to encapsulate dexamethasone sodium phosphate (DSP) into a patient’s own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, Ataxia-Telangiectasia (A-T). Its AIDE technology is designed to allow for the chronic administration of drugs that have limitations due to toxicity, poor biodistribution, suboptimal pharmacokinetics, or immune response. The AIDE technology platform delivers a variety of therapeutics, ranging from small to large molecules drugs and biologics.

Webull offers Quince Therapeutics Inc stock information, including NASDAQ: QNCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNCX stock methods without spending real money on the virtual paper trading platform.